-
公开(公告)号:BR9909870A
公开(公告)日:2000-12-19
申请号:BR9909870
申请日:1999-04-12
Applicant: ABBOTT LAB
Inventor: MARING CLARENCE J , GU YU-GUI , CHEN HUI-JU , CHEN YUANWEI , DEGOEY DAVID A , FLOSI WILLIAM J , GIRANDA VINCENT L , GRAMPOVNIK DAVID J , KATI WARREN M , KEMPF DALE J , KLEIN LARRY L , KRUEGER ALLAN C , LIN ZHEN , MADIGAN DAROLD L , MCDANIEL KEITH F , MUCHMORE STEVEN W , SHAM HING L , STEWART KENT D , STOLL VINCENT S , SUN MINGHUA , WANG SHELDON , XU YIBO , YEUNG MING C , ZHAO CHEN , KENNEDY APRIL
IPC: A61K31/401 , A61K31/4025 , A61K31/41 , A61K31/4155 , A61K31/4178 , A61K31/422 , A61K31/4245 , A61K31/427 , A61K31/433 , A61K31/5377 , A61P31/16 , A61P43/00 , C07D207/16 , C07D207/32 , C07D207/325 , C07D207/327 , C07D401/12 , C07D403/04 , C07D403/06 , C07D405/04 , C07D405/06 , C07D405/14 , C07D409/04 , C07D409/06 , C07D409/14 , C07D413/04 , C07D413/14 , C07D417/04 , C07D417/06 , C07D521/00 , C07F9/572 , A61K31/40 , C07D407/04
-
公开(公告)号:ES2426965T3
公开(公告)日:2013-10-28
申请号:ES10176829
申请日:2004-11-10
Applicant: ABBOTT LAB , ABBVIE INC
Inventor: FLENTGE CHARLES A , CHEN HUI-JU , DEGOEY DAVID A , FLOSI WILLIAM J , GRAMPOVNIK DAVID J , HUANG PEGGY P , KEMPF DALE J , KLEIN LARRY L , KRUEGER ALLAN C , MADIGAN DAROLD L , RANDOLPH JOHN T , SUN MINGHUA , YEUNG MING C , ZHAO CHEN
IPC: C07D417/06 , A61K31/175 , A61K31/18 , A61K31/195 , A61K31/277 , A61K31/4166 , A61K31/4168 , A61K31/4178 , A61K31/65 , A61K45/06 , A61P31/18 , C07C311/17 , C07D213/30 , C07D213/40 , C07D213/78 , C07D233/32 , C07D233/72 , C07D277/28 , C07D277/46 , C07D277/48 , C07D307/20 , C07D307/42 , C07D401/06 , C07D403/06 , C07D403/10 , C07D405/06 , C07D405/10 , C07D409/06 , C07D417/14 , C07D471/04 , C07D493/04
Abstract: Un compuesto que tiene la fórmula (V)**Fórmula** o una forma de sal farmacéuticamente aceptable, estereoisómero, éster, sal de un éster, o combinación de éstos, enel que X es O, S o NH; Y es O, S o NH; R es alquilo, alquenilo, cicloalquilo, cicloalquenilo, cicloalquilalquilo, cicloalquenilalquilo, arilalquilo o heteroarilalquilo;en el que cada R está sustituido con 0, 1 ó 2 sustituyentes seleccionados del grupo que consiste en alquilo,alquenilo, alquinilo, ciano, halo, formilo, nitro, hidroxi, alcoxi, -NH2, -N(H)alquilo, -N(alquilo)2, -C(>=O)OH,-C(>=O)Oalquilo, haloalquilo, hidroxialquilo y alcoxialquilo; R1 es ORa, -OSO2Ra, -OSO3Ra, -OPO3Ra, -OC(>=O)C(H)(R1a)NRaRb o -OC(>=O)C(H)(R1a)N(H)C(O)ORa;R1a es hidrógeno, alquilo, alquenilo, alquinilo, cicloalquilo, cicloalquenilo, arilo, arilalquilo, heteroarilo oheteroarilalquilo; en el que cada R1a está sustituido con 0, 1 ó 2 sustituyentes seleccionados independientemente delgrupo que consiste en halo, alquilo, alquenilo, alquinilo, -ORa, -SRa, -SORa, -SO2Ra, -SO2NRaRb, -C(>=O)Ra, -NRaRb,-N(Rb)C(>=O)Ra, -N(Rb)C(>=O)ORa, -N(Rb)SO2Ra, -N(Ra)SO2NRaRb, -N(Rb)C(>=NH)NRaRb, -N(Rb)C(>=O)NRaRb,-C(>=O)NRaRb y -C(>=O)ORa; R2 es H; R3 es alquilo, haloalquilo, alquenilo, haloalquenilo, alquinilo, haloalquinilo, cicloalquilo, cicloalquenilo,cicloalquenilalquilo, cicloalquilalquilo, heterociclo, heterocicloalquilo, heteroarilo, heteroarilalquilo, arilo, arilalquilo,hidroxialquilo, alcoxialquilo, haloalcoxialquilo, -alquiloSRa, -alquiloSORa, -alquiloSO2Ra, -alquiloNRaRb,-alquiloN(Rb)C(>=O)ORa, -alquiloN(Rb)C(>=O)Ra, -alquiloN(Rb)SO2Ra o -alquiloN(Rb)SO2NRaRb; en el que cada uno delos restos cicloalquilo, cicloalquenilo, arilo, heteroarilo, heterociclo, cicloalquilo del cicloalquilalquilo, restocicloalquenilo del cicloalquenilalquilo, resto heterociclo del heterocicloalquilo, resto heteroarilo del heteroarilalquilo,resto arilo del arilalquilo está sustituido independientemente con 0, 1, 2 ó 3 sustituyentes seleccionadosindependientemente del grupo que consiste en halo, nitro, ciano, formilo, alquilo, alquenilo, alquinilo, hidroxi, alcoxi,-SH, -S(alquilo), -SO2(alquilo), -NH2, -N(H)(alquilo), - N(alquilo)2, -N(H)C(>=O)alquilo, -N(alquilo)C(>=O)alquilo,-C(>=O)OH, -C(>=O)O(alquilo), -C(>=O)NH2, -C(>=O)N(H)(alquilo), -C(>=O)N(alquilo)2, -C(>=O)alquilo, haloalquilo,hidroxialquilo, alcoxialquilo, cianoalquilo, formilalquilo, nitroalquilo, -alquiloSH, -alquiloS(alquilo), -alquiloSO2(alquilo),-alquiloNH2, -alquiloN(H)(alquilo), -alquiloN(alquilo)2, -alquiloN(H)C(>=O)alquilo, -alquiloN(alquilo)C(>=O)alquilo,-alquiloC(>=O)OH, -alquiloC(>=O)O(alquilo), -alquiloC(>=O)NH2, -alquiloC(>=O)N(H)(alquilo), -alquiloC(>=O)N(alquilo)2,-alquiloC(>=O)alquilo y R3a.
-
公开(公告)号:BRPI0918724A2
公开(公告)日:2013-06-18
申请号:BRPI0918724
申请日:2009-09-10
Applicant: ENANTA PHARM INC , ABBOTT LAB
Inventor: KU YIYIN , MCDANIEL KEITH F , CHEN HUI-JU , SHANLEY JASON P , KEMPF DALE J , GRAMPOVNIK DAVID J , SUN YING , LIU DONG , GAI YONGHUA , OR YAT SUN , WAGAN SABLE H , ENGSTROM KEN , GRIEME TIM , SHEIKH AHMAD , MEI JIANZHANG
Abstract: The present invention relates to novel macrocyclic compounds and methods of use thereof. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.
-
公开(公告)号:AU2013205040A1
公开(公告)日:2013-05-16
申请号:AU2013205040
申请日:2013-04-13
Applicant: ABBOTT LAB , ENANTA PHARM INC
Inventor: KU YIYIN , MCDANIEL KEITH F , CHEN HUI-JU , SHANLEY JASON P , KEMPF DALE J , GRAMPOVNIK DAVID J , SUN YING , LIU DONG , YONGHUA GAI , OR YAT SUN , WAGAW SABLE H , ENGSTROM KEN , GRIEME TIM , SHEIKH AHMAD , MEI JIANZHANG
Abstract: MACROCYCLIC HEPATITIS C SERINE PROTEASE Abstract The present invention relates to novel macrocyclic compounds and methods of use thereof. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutical acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutical carrier or excipient.
-
公开(公告)号:SG179414A1
公开(公告)日:2012-04-27
申请号:SG2012014080
申请日:2009-09-10
Applicant: ABBOTT LAB , ENANTA PHARM INC
Inventor: KU YIYIN , MCDANIEL KEITH F , CHEN HUI-JU , SHANLEY JASON P , KEMPF DALE J , GRAMPOVNIK DAVID J , SUN YING , LIU DONG , GAI YONGHUA , OR YAT SUN , WAGAW SABLE H , ENGSTROM KEN , GRIEME TIM , SHEIKH AHMAD , MEI JIANZHANG
Abstract: The present invention relates to novel macrocyclic compounds and methods of use thereof. The present invention further relates to pharmaceutical compositions comprising the compounds of the present invention, or pharmaceutically acceptable salts, esters, or prodrugs thereof, in combination with a pharmaceutically acceptable carrier or excipient.
-
公开(公告)号:CR20110123A
公开(公告)日:2011-07-11
申请号:CR20110123
申请日:2011-03-07
Applicant: ENANTA PHARM INC , ABBOTT LAB
Inventor: KU YIYIN , MCDANIEL KEITH F , CHEN HUI-JU , SHANLEY JASON P , KEMPF DALE J , GRAMPOVNIK DAVID J , SUN YING , LIU DONG , GAI YONGHUA , OR YAT SUN , WAGAW SABLE H , ENGSTROM KEN , GRIEME TIM , SHEIKH AHMAD , MEI JIANZHANG
Abstract: La presente invención se relaciona con nuevos compuestos macrocíclicos y con métodos de uso de los mismos. La presente invención también se relaciona con composiciones farmacéuticas que comprenden los compuestos de la presente invención, o las sales, ésteres o prodrogas farmacéuticamente aceptables, en combinación con un vehículo o excipiente farmacéuticamente aceptable.
-
公开(公告)号:CA2661873A1
公开(公告)日:2008-03-06
申请号:CA2661873
申请日:2007-08-29
Applicant: ABBOTT LAB
Inventor: CHEN HUI-JU , KLEIN LARRY L , HUTCHINSON DOUGLAS K , YEUNG MING C , KEMPF DALE J , HUANG PEGGY P , FLENTGE CHARLES A , RANDOLPH JOHN T
IPC: C07D277/24 , A61K31/426 , A61K31/427 , A61P43/00 , C07D417/12
Abstract: The present invention features compounds of formula (I) or pharmaceutical ly acceptable salts, solvates or prodrugs thereof, and describes methods of using the same to inhibit the metabolizing activities of CYP enzymes. The pr esent invention also describes methods of using these compounds, salts, solv ates or prodrugs to improve the pharmacokinetics of drugs that are metaboliz ed by CYP enzymes.
-
公开(公告)号:HK1100037A1
公开(公告)日:2007-08-31
申请号:HK07103390
申请日:2007-03-29
Applicant: ABBOTT LAB DEPT
Inventor: FLENTGE CHARLES A , CHEN HUI-JU , DEGOEY DAVID A , FLOSI WILLIAM J , GRAMPOVNIK DAVID J , HUANG PEGGY P , KEMPF DALE J , KLEIN LARRY L , KRUEGER ALLAN C , MADIGAN DAROLD L , RANDOLPH JOHN T , SUN MINGHUA , YEUNG MING C , ZHAO CHEN
IPC: A61K31/175 , A61K31/18 , A61K31/195 , A61K31/277 , A61K31/4168 , A61K31/65 , A61K45/06 , C07C311/17 , C07D20100101 , C07D213/30 , C07D213/40 , C07D213/78 , C07D233/32 , C07D233/72 , C07D277/28 , C07D277/46 , C07D277/48 , C07D307/20 , C07D307/42 , C07D401/06 , C07D403/06 , C07D403/10 , C07D405/06 , C07D405/10 , C07D409/06 , C07D417/06 , C07D417/14 , C07D471/04 , C07D493/04
Abstract: A compound of the formula is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.
-
公开(公告)号:HK1094579A1
公开(公告)日:2007-04-04
申请号:HK07101712
申请日:2007-02-13
Applicant: ABBOTT LAB
Inventor: RANDOLPH JOHN T , CHEN HUI-JU , DEGOEY DAVID A , FLENTGE CHARLES A , FLOSI WILLIAM J , GRAMPOVNIK DAVID J , HUANG PEGGY P , HUTCHINSON DOUGLAS K , KEMPF DALE J , KLEIN LARRY L , YEUNG MING C
IPC: A61K20060101 , A61P20060101 , C07C20060101 , C07D20060101
-
公开(公告)号:CA2792483A1
公开(公告)日:2005-07-07
申请号:CA2792483
申请日:2004-11-10
Applicant: ABBOTT LAB
Inventor: FLENTGE CHARLES A , CHEN HUI-JU , DEGOEY DAVID A , FLOSI WILLIAM J , GRAMPOVNIK DAVID J , HUANG PEGGY P , KEMPF DALE J , KLEIN LARRY L , KRUEGER ALLAN C , MADIGAN DAROLD L , RANDOLPH JOHN T , SUN MINGHUA , YEUNG MING C , ZHAO CHEN
IPC: C07D277/20 , A61K31/175 , A61K31/18 , A61K31/195 , A61K31/27 , A61K31/277 , A61K31/341 , A61K31/4168 , A61K31/426 , A61K31/44 , A61K31/65 , A61K45/06 , A61P31/18 , C07C311/00 , C07C311/17 , C07D213/00 , C07D213/30 , C07D213/40 , C07D213/78 , C07D233/32 , C07D233/72 , C07D277/28 , C07D277/46 , C07D277/48 , C07D307/20 , C07D307/42 , C07D401/06 , C07D403/06 , C07D403/10 , C07D405/06 , C07D405/10 , C07D409/06 , C07D417/06 , C07D417/14 , C07D471/04 , C07D493/04
Abstract: A compound of the formula is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.
-
-
-
-
-
-
-
-
-